A few studies have suggested that bladder cancer cells could initiate an immune response by presenting antigen to CD4 T cells [25,26,27,28,29]; however, the ability to effectively present antigen and activate CD4 T cells is generally limited to professional antigen presenting cells. This evidence concerns the gene CD4 and urinary bladder carcinoma.